Data as of Dec 19
 -0.01 / -0.39%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

CytRx Corp. is engaged in specializing oncology. It focuses on the clinical development of oncology pipelines for the treatment of cancer. It includes clinical-stage drug candidates in various stages of development such as Aldoxorubicin, Tamibarotene, and Bafenitib. The company was founded in 1985 and is headquartered in Los Angeles, CA.

Contact Information

CytRx Corp.
11726 San Vicente Boulevard
Los Angeles California 90049
P:(310) 826-5648
Investor Relations:



Individual stakeholders9.83%
Other institutional23.04%
Mutual fund holders14.75%

Top Executives

Steven A. KriegsmanPresident, Chief Executive Officer & Director
John Y. CalozChief Financial Officer & Treasurer
Daniel J. LevittChief Medical Officer & Executive Vice President
David J. HaenVP-Business Development & Head-Investor Relations
Douglas Scott WielandSenior Vice President-Drug Development

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.